PuSH - Publikationsserver des Helmholtz Zentrums München

An overview of the latest metabolomics studies on atopic eczema with new directions for study.

Int. J. Mol. Sci. 23:8791 (2022)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Atopic eczema (AE) is an inflammatory skin disorder affecting approximately 20% of children worldwide and early onset can lead to asthma and allergies. Currently, the mechanisms of the disease are not fully understood. Metabolomics, the analysis of small molecules in the skin produced by the host and microbes, opens a window to observe the mechanisms of the disease which then may lead to new drug targets for AE treatment. Here, we review the latest advances in AE metabolomics, highlighting both the lipid and non-lipid molecules, along with reviewing the metabolites currently known to reside in the skin.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
6.208
0.000
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Atopic Eczema ; Atopic Dermatitis ; Dermatitis ; Metabolomics ; Skin ; Lipidomics
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 1661-6596
e-ISSN 1422-0067
Quellenangaben Band: 23, Heft: 15, Seiten: , Artikelnummer: 8791 Supplement: ,
Verlag MDPI
Verlagsort Basel
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit BioGeoChemistry and Analytics (BGC)
Institute of Environmental Medicine (IEM)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Environmental Sciences
Allergy
PSP-Element(e) G-504800-001
G-503400-001
Förderungen Center for Allergy Research and Education
Helmholtz Association
International Visegrad Fund
Christine Kühne – Center for Allergy Research and Education
Scopus ID 85136341202
PubMed ID 35955924
Erfassungsdatum 2022-09-19